ORARI:
Lun/Ven
9:00 - 13:00
14:00 - 18:00

Wellmicro Srl è un progetto co-finanziato da:

Wellmicro Srl è partner del progetto dell'Unione Europea Horizon 2020 (grant agreement No 818290):

I NOSTRI SERVIZI

IL MICROBIOPASSPORT®

E’ semplice, intuitivo e non invasivo. Il Microbiopassport® è il primo metodo di analisi del microbiota intestinale brevettato che permette di conoscere la tua composizione microbica intestinale per supportare la pianificazione di un corretto approccio nutrizionale e/o terapeutico.

Ordina il tuo KIT

Cos'è?

Come funziona?

REFERENZE

Di seguito sono riportati alcuni degli studi alla base del metodo Microbiopassport®:

Bhattarai et al.; Irritable bowel syndrome: a gut microbiota-related disorder? // American Journal of Physiology-Gastrointest Liver Physiol

Erny et al.; Host microbiota constantly control maturation and function of microglia in the CNS // Nature

Turroni et al.; Microbiota–Host Transgenomic Metabolism, Bioactive Molecules from the Inside // Journal of Medicinal Chemistry

Clarke et a.; Gut Microbiota: The Neglected Endocrine Organ // Molecular Endocrinology

Mayer et al.; The Gut and Its Microbiome as Related to Central Nervous System Functioning and Psychological Well-being: Introduction to the Special Issue of Psychosomatic Medicine // Psychosomatic Medicine

Wang et al.; Increased abundance of Sutterella spp. and Ruminococcus torques in feces of children with autism spectrum disorder // Molecular Autism

Kampmann et al.; Composition of human faecal microbiota in resistance to Campylobacter infection // Clinical Microbiology and Infection

Schoubert et al.; Antibiotic-Induced Alterations of the Murine Gut Microbiota and Subsequent Effects on Colonization Resistance against Clostridium difficile // Mbio

Schoubert et al.; Microbiome Data Distinguish Patients with Clostridium difficile Infection and Non-C. difficile-Associated Diarrhea from Healthy Controls // Mbio

Sun et al.; Regulation of bacterial pathogenesis by intestinal short-chain Fatty acids // Advances in Applied Microbiology

Stecher et al.; The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection // Microbiology Spectrum

Charlie et al.; Microbiota-mediated colonization resistance against intestinal pathogens // Nature

Yurist-Doutsch et al.; Gastrointestinal Microbiota–Mediated Control of Enteric Pathogens // Annual Review of Genetics

Hiippala et al.; The Potential of Gut Commensals in Reinforcing Intestinal Barrier Function and Alleviating Inflammation // Nutrients

Emoto et al.; Analysis of Gut Microbiota in Coronary Artery Disease Patients: a Possible Link between Gut Microbiota and Coronary Artery Disease // Journal of Atherosclerosis and Thrombosis

Brahe et al.; Specific gut microbiota features and metabolic markers in postmenopausal women with obesity // Nutrition & Diabetes

Shin et al.; An increase in the Akkermansia spp. population induced by metformin treatment improves glucose homeostasis in diet-induced obese mice // Gut

Sokol et al.; Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients // Proceedings of the National Academy of Sciences of the United States of America

Vieira et al.; The role of probiotics and prebiotics in inducing gut immunity // Frontiers in Immunology

Cao et al.; Association between Faecalibacterium prausnitzii Reduction and Inflammatory Bowel Disease: A Meta-Analysis and Systematic Review of the Literature // Gastroenterology Research and Practice

Tilg et al.; Microbiota and diabetes: an evolving relationship // Gut

Karlsson et al.; The microbiota of the gut in preschool children with normal and excessive body weight // Obesity

Cani et al.; Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia // Diabetologia

Fleissner et al.; Absence of intestinal microbiota does not protect mice from diet-induced obesity // The British Journal of Nutrition

Woting et al.; Clostridium ramosum Promotes High-Fat Diet-Induced Obesity in Gnotobiotic Mouse Models // MBio

Le Chatelier et al.; Richness of human gut microbiome correlates with metabolic markers // Nature

Ferrer et al.; Microbiota from the distal guts of lean and obese adolescents exhibit partial functional redundancy besides clear differences in community structure // Environmental Microbiology

Turnbaugh et al.; The effect of diet on the human gut microbiome: a metagenomic analysis in humanized gnotobiotic mice // Science Translational Medicine

Tilg et al.; Microbiota and diabetes: an evolving relationship // Gut

Zhang et al.; Human gut microbiota in obesity and after gastric bypass // Proceedings of the National Academy of Sciences of the United States of America

Qin et al.; A metagenome-wide association study of gut microbiota in type 2 diabetes //Nature

Karlsson et al.; Symptomatic atherosclerosis is associated with an altered gut metagenome // Nature Communications

Lahti et al.; Associations between the human intestinal microbiota, Lactobacillus rhamnosus GG and serum lipids indicated by integrated analysis of high-throughput profiling data // PeerJ

Berry et al.; Intestinal microbiota: a source of novel biomarkers in inflammatory bowel diseases? // Best Practice & Research Clinical Gastroenterology

Machiels et al.; A decrease of the butyrate-producing species Roseburia hominis and Faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitis // Gut

Morgan et al.; Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment // Genome Biology

Turnbaugh; Microbiology: fat, bile and gut microbes // Nature

Rowan et al.; Sulphate‐reducing bacteria and hydrogen sulphide in the aetiology of ulcerative colitis // British Journal of Surgery
Ijssennagger et al.; Sulfide as a Mucus Barrier-Breaker in Inflammatory Bowel Disease? // Trends in Molecular Medicine

Michielan et al.; Intestinal Permeability in Inflammatory Bowel Disease: Pathogenesis, Clinical Evaluation, and Therapy of Leaky Gut, // Mediators of Inflammation

Biagi et al.; Through ageing, and beyond: gut microbiota and inflammatory status in seniors and centenarians // Plos One

Biagi et al.; Aging of the human metaorganism: the microbial counterpart // Age

Biagi et al.; Ageing and gut microbes: perspectives for health maintenance and longevity // Pharmacological Research

Rampelli et al.; Functional metagenomic profiling of intestinal microbiome in extreme ageing // Aging

Biagi et al.; Gut microbiome in down syndrome // Plos One

Consulenza e Assistenza

PER LA RICERCA:
Ci proponiamo come partner per accompagnarvi nella pianificazione e nell’esecuzione di studi sul microbiota finalizzati sia alla ricerca scientifica che allo sviluppo di prodotti commerciali. Anni di esperienza a livello internazionale al servizio di tutti.

PER IL PROFESSIONISTA:
La nostra assistenza è sempre al fianco del professionista per approfondimenti scientifici sui test eseguiti. Contattaci e risolveremo ogni dubbio.

Scopri di più

Formazione - WELLMICRO ACADEMY

Organizziamo corsi di formazione rivolti a medici, professionisti del settore e nutrizionisti, per illustrare il tipo di attività svolta e le differenti tipologie di analisi effettuate. In questa sede potrai approfondire lo stato dell’arte della più aggiornata letteratura scientifica sul microbiota umano, comprendere i razionali scientifici dei nostri test ed eseguire prove pratiche per la migliore interpretazione dei profili microbici riscontrabili.

Scopri di più

I NOSTRI SERVIZI

IL MICROBIOPASSPORT®

Consulenza e Assistenza

Formazione - WELLMICRO ACADEMY

Contatti

seguici sui social